The 2026 AAD Annual Meeting put treatment selection for pediatric acne and rosacea in front of dermatologists choosing care for children and teens. The central decision is which treatment fits the child's age, lesion type, and severity while limiting resistance and side effects.
Acne means clogged pores, pimples, and deep painful bumps. Rosacea means lasting redness plus pimples-like bumps, visible vessels, and sometimes eye irritation. Incyte noted via Business Wire that the meeting was held March 27-31, 2026 in Denver to share pipeline updates and late-breaking data, described in a meeting preview from Incyte via Business Wire.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What do acne guidelines favor first?
- How does age narrow acne choices?
- Why is pediatric rosacea handled differently?
- Which rosacea symptom should treatment target?
What do acne guidelines favor first?
The American Academy of Dermatology guidance gives strong recommendations for topical benzoyl peroxide, topical retinoids, antibiotics only in fixed-dose combinations, oral doxycycline, and oral isotretinoin for severe acne. The guidance is summarized in Medical Dialogues in a summary of the AAD guidance in Medical Dialogues. That means single-agent topical antibiotics are out.
AAD stewardship advice reported by Medscape urges prescribers to avoid topical antibiotic monotherapy, add benzoyl peroxide when oral antibiotics are used, and keep systemic courses short. For parents, the practical question is whether the plan pairs the antibiotic with benzoyl peroxide or a retinoid. Ask how long the oral antibiotic will run and what topical will remain after it stops.
How does age narrow acne choices?
Age cutoffs decide which prescription topicals a child can use. U.S.
FDA labeling sets tretinoin/benzoyl peroxide cream Twyneo at age 9 and older, detailed in the FDA label for tretinoin and benzoyl peroxide cream, while Sun Dermatology regulatory material sets clascoterone cream Winlevi at 12 and older. Oral tetracyclines need extra caution in younger children. FDA doxycycline labeling warns against routine use during tooth development up to age 8 because of permanent tooth color change and reversible slowing of bone growth.
- Under 8: flag tooth and bone warnings before accepting a tetracycline.
- Ages 9-11: ask whether a 9-and-older topical fits before considering systemic therapy.
- Age 12 and older: ask whether older-child options add benefit over the current regimen.
Why is pediatric rosacea handled differently?
Pediatric rosacea has no dedicated FDA approvals, so doctors adapt adult regimens with age adjustments. A Dermatology Times review summary found topical erythromycin, azithromycin, and metronidazole were the most commonly reported pediatric treatments. That adaptation makes eye screening important.
The same review points to ocular checks to separate rosacea from acne, since redness, burning, styes, and light sensitivity point away from typical acne. Parents should bring eye symptoms, flushing triggers, and family rosacea history to the visit. Journey Medical reported that Emrosi, a 40-mg modified-release minocycline, won FDA approval in November 2024 for inflammatory rosacea bumps in adults, not children, which shows why adult approval alone does not settle a child's plan.
Which rosacea symptom should treatment target?
Rosacea care works best when matched to the visible pattern. Skin Therapy Letter describes brimonidine and oxymetazoline for persistent redness, and azelaic acid, ivermectin, metronidazole, minocycline, doxycycline, and encapsulated benzoyl peroxide for bumps and pustules.
Vessels need another tool. The same source lists lasers for telangiectasia, the fine visible blood vessels that creams do not remove.
- Lasting redness: ask about redness-targeted topicals.
- Bumps and pustules: ask about anti-inflammatory topicals or age-appropriate oral therapy.
- Visible vessels: ask about referral for vessel-directed laser care.
- Eye burning or styes: ask about eye evaluation before changing skin therapy.
You Might Also Like
- Pediatric Acne and Rosacea at the 2026 AAD Annual Meeting: Questions Pediatric Dermatology Patients Can Ask a Dermatologist
- Pediatric Acne and Rosacea at the 2026 AAD Annual Meeting: Diagnosis and Look-Alike Questions for Pediatric Dermatology Patients
- Pediatric Acne and Rosacea at the 2026 AAD Annual Meeting: What the Update Means for Pediatric Dermatology Patients